GO:0032991 protein-containing complex: Components, Assembly and Research Methods

A protein-containing complex (GO:0032991) is a stable assembly of two or more macromolecules in which at least one component is a protein and the constituent parts function together [1,2]. This Gene Ontology cellular_component term captures the fundamental principle that many cellular activities are not carried out by isolated polypeptides but by ordered, multi-subunit machines. Examples include the WD40-repeat-containing deubiquitinase complex, which combines substrate recognition and catalytic modules to regulate ubiquitin signaling, and nucleic acid-sensing inflammasomes, which assemble into large signaling platforms upon detection of microbial or host-derived ligands [4,8]. The term also encompasses assemblies that include non-protein macromolecules, such as nucleic acids, carbohydrates, or lipids, provided at least one protein component is present [1,3]. Why does GO:0032991 matter for researchers? First, complex membership often defines protein function more accurately than sequence alone; a catalytic subunit may be inert until incorporated into a complex with the correct architecture [2,7]. Second, complex assembly is frequently the regulated step in signaling and stress responses, as illustrated by inflammasome activation and autophagy regulation [4,7,8]. Third, disease mutations can alter complex stability or dynamics; the ALS-associated FUS protein undergoes a liquid-to-solid phase transition that is accelerated by disease mutation, linking complex material properties to neurodegeneration. Fourth, extracellular complexes such as ASC specks can act beyond their canonical intracellular roles, revealing unknown or enigmatic functions of assembled complexes in immunity. Finally, protein-containing complexes are tractable experimental targets: they can be purified, tethered, and mechanically probed, and their components can be genetically perturbed using CRISPR [5,6]. This article provides a research-grade overview of GO:0032991, covering its definition, biological significance, structural and molecular mechanisms, key genes, disease links, and the experimental methods, including CRISPR-based models, used to study protein-containing complexes. All statements are grounded in the verified literature cited by number.

In our own words, GO:0032991 (protein-containing complex) describes any stable assembly of two or more macromolecules, where at least one macromolecule is a protein, and the assembled parts function together as a unit. The macromolecular components can include proteins, nucleic acids, carbohydrates, or lipids [1,2]. The term is intentionally broad: it covers obligate heterodimers, transient signaling platforms, and large multi-subunit machines such as inflammasomes and autophagy-regulatory complexes [3,4,7]. Stability and functional cooperation are the defining features, distinguishing protein-containing complexes from random molecular collisions or non-functional aggregates [1,5].

Protein-containing complexes are central to nearly every cellular process because they concentrate, orient, and regulate macromolecules in space and time. The WD40-repeat-containing deubiquitinase complex illustrates how combining a scaffold and a catalytic module creates specificity in ubiquitin signaling. Inflammasomes demonstrate how nucleic acid sensing triggers assembly of a signaling platform that drives inflammatory responses [4,8]. Autophagy regulation by the Atg14L-containing Beclin 1-Vps34 complex shows how complex architecture directly controls lipid kinase output and phosphatidylinositol-3 phosphate levels. Disease mutations can corrupt complex material properties, as in FUS phase transitions linked to ALS. Thus, understanding GO:0032991 is essential for mechanistic biology, drug target discovery, and the design of CRISPR models that test causality [5,6].

The following genes and proteins represent well-documented components or regulators of protein-containing complexes discussed in the verified literature.

Protein-containing complexes are regulated at multiple levels. Inflammasome activation is controlled by transcriptional, post-translational, and assembly-dependent mechanisms to prevent inappropriate inflammation. The Atg14L-containing Beclin 1-Vps34 complex is modulated by Nrbf2, which changes complex architecture and reduces intracellular phosphatidylinositol-3 phosphate levels, thereby suppressing autophagy. TATA-binding-protein-containing complexes are regulated during mitosis, indicating cell-cycle-dependent control. Disease mutations can also alter regulation, as ALS-associated mutations accelerate the liquid-to-solid phase transition of FUS-containing assemblies. These examples show that regulation occurs through changes in composition, modification, and material state [1,6,7,8].

Protein-containing complexes can undergo pathological phase transitions. The ALS-associated protein FUS forms liquid droplets that transition to solid-like states, and disease mutations accelerate this process. This links the material properties of protein-containing assemblies to neurodegeneration and suggests that stabilizing or reversing aberrant transitions could be therapeutic.

Inflammasomes are nucleic acid-sensing protein-containing complexes that drive inflammatory responses [4,8]. Their dysregulation contributes to autoinflammatory disease, and extracellular ASC specks have enigmatic functions that may amplify inflammation. Understanding inflammasome assembly and regulation is therefore central to immune disease research [3,4,8].

The Atg14L-containing Beclin 1-Vps34 complex controls autophagy and phosphatidylinositol-3 phosphate levels, processes frequently altered in cancer. Nrbf2 modulates this complex to suppress autophagy, highlighting how complex architecture influences cell survival and stress responses. Targeting autophagy-regulatory complexes is an active area of cancer research.

WD40-repeat-containing deubiquitinase complexes integrate catalysis and regulation and have potential for therapeutic intervention. Because these complexes control ubiquitin signaling, small molecules or genetic tools that disrupt complex assembly could modulate disease-relevant pathways.

Affinity purification of tagged complex components followed by mass spectrometry identifies subunits and stoichiometry. This approach is foundational for defining membership in GO:0032991 and has been applied to deubiquitinase and autophagy-regulatory complexes [2,7].

Tethering complex proteins and protein complexes for optical tweezers experiments allows controlled force measurements of assembly and stability. This method provides quantitative biophysical data on how complexes hold together under load.

Live-cell imaging and droplet assays reveal liquid-like behavior and transitions to solid states. FUS-containing assemblies have been characterized this way, showing that disease mutations accelerate the liquid-to-solid transition.

Measuring downstream products such as phosphatidylinositol-3 phosphate levels or cytokine release reports on complex activity. These assays have been used to show that Nrbf2 modulates the Atg14L-containing Beclin 1-Vps34 complex and that inflammasomes drive inflammatory signaling [4,7,8].

Researchers studying protein-containing complex-related genes often need to determine whether a candidate gene is causally involved in complex assembly, function, or disease. EDITGENE provides publication-ready CRISPR models and bioinformatics support to accelerate this work.

GO:0032991 (protein-containing complex) is a foundational cellular_component term that captures how macromolecules assemble into functional machines. From inflammasomes and autophagy-regulatory complexes to phase-separated FUS assemblies, these complexes control immunity, homeostasis, transcription, and disease [1,2,4,6,7,8]. Understanding their assembly, architecture, regulation, and dynamics requires integrated biochemical, biophysical, and genetic approaches [1,5,7]. CRISPR-based models, including knockout, point mutation, knock-in, and overexpression, provide causal tools to dissect complex components and their roles in disease [1,2,5]. With EDITGENE services spanning these models plus library screening and bioinformatics, researchers can accelerate discovery in protein-containing complex biology.